Related Experiment Video

Updated: Sep 26, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

292

Targeting AML at the intersection of epigenetics and signaling

Nisha Narayan1,2, Brian J P Huntly1,2,3

  • 1Wellcome-MRC Cambridge Stem Cell Institute, Cambridge CB2 0AW, UK.

Science Signaling
|April 19, 2022
PubMed

Insights

Mutations in acute myeloid leukemia (AML) can disrupt cell differentiation by altering epigenetic and transcriptional states. Inhibiting epigenetic regulators may enhance cancer cell sensitivity to targeted kinase inhibitors.

Area of Science:

  • Cancer Biology
  • Epigenetics
  • Molecular Signaling

Background:

  • Cancer development involves complex genetic and epigenetic alterations.
  • Aberrant signaling pathways are hallmarks of various cancers, including acute myeloid leukemia (AML).
  • The interplay between epigenetic dysregulation and signaling pathway corruption is crucial in cancer progression.

Purpose of the Study:

  • To investigate the intersection of epigenetic and transcriptional alterations in regulating cellular differentiation in AML.
  • To determine if inhibiting epigenetic regulators can sensitize AML cells to kinase inhibitors.

Main Methods:

  • Analysis of cellular epigenetic and transcriptional states in AML.
  • Investigation of key signaling pathways affected by mutations.
  • Experimental models to assess the effect of epigenetic regulator inhibition on kinase inhibitor sensitivity.

Main Results:

  • Demonstrated a synergistic effect of mutations on epigenetic and transcriptional states in AML.
  • Illustrated the intersection of epigenetic and transcriptional regulation in cellular differentiation.
  • Showed that inhibiting epigenetic regulators enhances AML cell sensitivity to kinase inhibitors.

Conclusions:

  • Epigenetic and transcriptional alterations synergistically disrupt cellular differentiation in AML.
  • Targeting epigenetic regulators represents a potential therapeutic strategy to improve the efficacy of kinase inhibitors in AML treatment.

More Related Videos

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.3K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.4K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.9K